Radioactive drug trial offers hope for Tough-to-Treat sarcomas
Disease control
Recruiting now
This early-stage study is testing a new radioactive drug, [Ac225]RTX-2358, for people with advanced soft tissue sarcoma that has come back or hasn't responded to other treatments. The main goals are to find the safest and most effective dose and to see if the drug helps control t…
Phase: PHASE1 • Sponsor: Ratio Therapeutics, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC